Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Paragon Care Limited ( (AU:PGC) ) just unveiled an update.
Paragon Care Limited announced a change in the director’s interest, with Carmen Riley acquiring 3,018,108 Performance Rights, as approved at the company’s Annual General Meeting. This change reflects the company’s ongoing commitment to aligning its leadership’s interests with its strategic goals, potentially impacting its operational focus and stakeholder engagement.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.26 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited operates in the healthcare sector, providing medical equipment, devices, and consumables. The company focuses on delivering innovative healthcare solutions and services to hospitals, medical centers, and other healthcare providers.
YTD Price Performance: -45.83%
Average Trading Volume: 578,604
Technical Sentiment Signal: Sell
Current Market Cap: A$430.4M
For an in-depth examination of PGC stock, go to TipRanks’ Overview page.